BRISTOL-MYERS SQUIBB COMPANY (BMY) Dividend Safety
- Dividend payout ratio · 12 months: Value 54.89%; Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | 54.89% | Cash dividends paid / net income. Period ending 2026-06-30. $5.09B ÷ $9.28B × 100 ≈ 54.89% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | 5.09B USD | Payments of Dividends |
| Net income · 12 months | 9.28B USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | $5.09B | $9.28B | 54.89% |
| 2026-03-31 | $5.07B | $7.28B | 69.69% |
| 2025-12-31 | $5.04B | $7.05B | 71.52% |
| 2025-09-30 | $5.00B | $6.04B | 82.81% |
| 2025-06-30 | $4.95B | $5.05B | 98.12% |
| 2025-03-31 | $4.91B | $5.42B | 90.59% |
| 2024-12-31 | $4.86B | $-8.95B | -54.35% |
| 2024-09-30 | $4.80B | $-7.26B | -66.20% |
| 2024-06-30 | $4.78B | $-6.54B | -73.08% |
| 2024-03-31 | $4.76B | $-6.15B | -77.42% |
| 2023-12-31 | $4.74B | $8.03B | 59.12% |
| 2023-09-30 | $4.73B | $8.29B | 57.08% |
| 2023-06-30 | $4.69B | $7.96B | 58.92% |
| 2023-03-31 | $4.64B | $7.31B | 63.53% |
| 2022-12-31 | $4.63B | $6.33B | 73.24% |
| 2022-09-30 | $4.59B | $6.68B | 68.71% |
| 2022-06-30 | $4.52B | $6.62B | 68.37% |
| 2022-03-31 | $4.47B | $6.25B | 71.56% |
| 2021-12-31 | $4.40B | $6.99B | 62.85% |
| 2021-09-30 | $4.32B | $-5.41B | -79.89% |
| 2021-06-30 | $4.24B | $-5.08B | -83.56% |
| 2021-03-31 | $4.17B | $-6.22B | -66.99% |
| 2020-12-31 | $4.08B | $-9.02B | -45.20% |
| 2020-09-30 | $3.72B | $-44.00M | -8459.09% |
| 2020-06-30 | $3.38B | $-563.00M | -599.82% |
| 2020-03-31 | $3.03B | $954.00M | 317.30% |
| 2019-12-31 | $2.68B | $3.44B | 77.90% |
| 2019-09-30 | $2.66B | $5.66B | 47.11% |
| 2019-06-30 | $2.65B | $6.20B | 42.66% |
| 2019-03-31 | $2.63B | $5.14B | 51.11% |
| 2018-12-31 | $2.61B | $4.92B | 53.11% |
| 2018-09-30 | $2.60B | $1.43B | 181.49% |
| 2018-06-30 | $2.59B | $376.00M | 687.77% |
| 2018-03-31 | $2.58B | $919.00M | 280.20% |
| 2017-12-31 | $2.58B | $1.01B | 255.91% |
| 2017-09-30 | $2.57B | $4.23B | 60.84% |
| 2017-06-30 | $2.57B | $4.59B | 56.02% |
| 2017-03-31 | $2.56B | $4.84B | 52.96% |
| 2016-12-31 | $2.55B | $4.46B | 57.15% |
| 2016-09-30 | $2.53B | $3.37B | 75.16% |
| 2016-06-30 | $2.51B | $2.87B | 87.49% |
| 2016-03-31 | $2.50B | $1.57B | 158.51% |
| 2015-12-31 | $2.48B | $1.56B | 158.27% |
| 2015-09-30 | $2.46B | $1.77B | 138.42% |
| 2015-06-30 | $2.44B | $1.79B | 136.15% |
| 2015-03-31 | $2.42B | $2.25B | 107.23% |
| 2014-12-31 | $2.40B | $2.00B | 119.66% |
| 2014-09-30 | $2.38B | $2.72B | 87.49% |
| 2014-06-30 | $2.36B | $2.69B | 87.69% |
| 2014-03-31 | $2.33B | $2.89B | 80.73% |
| 2013-12-31 | $2.31B | $2.56B | 90.09% |
| 2013-09-30 | $2.29B | $2.76B | 83.02% |
| 2013-06-30 | $2.29B | $1.36B | 168.29% |
| 2013-03-31 | $2.29B | $1.47B | 155.79% |
| 2012-12-31 | $2.29B | $1.96B | 116.63% |
| 2012-09-30 | $2.29B | $1.89B | 121.09% |
| 2012-06-30 | $2.28B | $3.57B | 63.86% |
| 2012-03-31 | $2.27B | $3.82B | 59.31% |
| 2011-12-31 | $2.25B | $3.71B | 60.77% |
| 2011-09-30 | $2.24B | $3.34B | 67.16% |
| 2011-06-30 | $2.23B | $3.32B | 67.14% |
| 2011-03-31 | $2.22B | $3.35B | 66.25% |
| 2010-12-31 | $2.20B | $3.10B | 70.99% |
| 2010-09-30 | $2.28B | $10.64B | 21.41% |
| 2010-06-30 | $2.35B | $10.66B | 22.09% |
| 2010-03-31 | $2.42B | $10.72B | 22.56% |
| 2009-12-31 | $2.48B | $10.61B | 23.40% |
| 2009-09-30 | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) |
| 2008-12-31 | $2.46B | $5.25B | 46.90% |
| 2008-09-30 | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | (m) |
| 2007-12-31 | $2.21B | $2.17B | 102.22% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |